Othman Jalal Ali

Othman Jalal Ali

Auto-generated profile, based on publicly available information

Othman Jalal Ali

University of Sulaimani

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2022 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
BMBushra Hassan Marouf
Bushra Hassan Marouf
DIDana Omer Ismaeel
Dana Omer Ismaeel
AHAli Hussein Hassan
Ali Hussein Hassan
OAOthman Jalal Ali
Othman Jalal Ali
Background: Current therapies for polycystic ovary syndrome (PCOS) are accompanied by unwanted effects. Silibinin; a flavonolignan has pleiotropic activities and favorable safety profile. Purpose: To investigate the efficacy of silibinin on estrous cyclicity, inflammation, oxidative stress and ovarian morphology in letrozole-induced PCOS in rats. Methods: Forty-eight female Wistar albino rats were divided into 2 sets. Rats of the first set (n = 12), assigned as a negative control (NC) received only the vehicle, rats of the second set (n = 36), assigned as PCOS rats, were given letrozole 1mg/Kg orally for 21 days. On day 21, six rats from the first set and six rats from the second set were euthanized for confirmation of PCOS-induction. The remaining animals from the first set assigned as group 1, those in the second set (n = 30) were equally divided into 5 groups and treated daily for 19 days as follows: group 2 (positive control) received only the vehicle, group 3 treated with metformin 300mg/Kg orally, groups 4 and 5 treated respectively with 100 and 200 mg/Kg silibinin intraperitoneally (IP), and group 6 treated with a combination of metformin 300mg/Kg orally and silibinin 100mg/Kg IP. On day 40, blood samples were examined for luteinizing hormone (LH), testosterone (TS) and estradiol (EST) levels, the anti-inflammatory and antioxidant parameters, ovarian and uterine morphology. Results: Silibinin alone or in combination with metformin was found to be effective in restoring the regularity of estrous cycle by ameliorating the abnormal alterations of LH, TS, EST, tumor necrosis factor (TNF)-α, and oxidative status and by resuming the appearance of corpora lutea and decreasing or even total absence of cystic follicles in the ovaries. Conclusion: Silibinin was effective in restoring estrous regularities and alleviating hormonal and histomorphological abnormalities of the ovarian and uterine tissues, this could be due to its anti-androgenic, anti-inflammatory and antioxidant properties.

22 October 2026 in Veterinary World
Verified
Journal Article
Open access
SMSozan Ali Muhamad
Sozan Ali Muhamad
OAOthman Jalal Ali
Othman Jalal Ali
Background and Aim: Silver nanoparticles (AgNPs) have potential applications in bone regeneration; however, the concentration-dependent effects of their direct local administration at fracture sites remain insufficiently characterized. This study evaluated the effects of a single local application of AgNPs at different concentrations on fracture healing in a stabilized rat femoral osteotomy model and assessed associated changes in antioxidant enzyme activity. Materials and Methods: Eighty healthy male albino rats, aged 5–6 months and weighing 300–350 g, were allocated equally to four groups (n = 20/group): control and AgNP treatments at 2.5, 5, and 10 μg/mL. Following standardized femoral osteotomy and intramedullary fixation, 1 mL of normal saline or the assigned AgNP suspension was administered once locally at the osteotomy site. Fracture healing was evaluated on postoperative days 7, 14, 21, and 30 using radiographic callus measurements, histological assessment, and histomorphometric quantification of osteoblasts, osteocytes, and osteoclasts. Catalase (CAT) and superoxide dismutase (SOD) activities were assessed on days 7 and 30. Results: Local AgNP administration showed concentration- and time-dependent differences in fracture healing. On day 30, callus diameters were 5.28 ± 0.09, 6.20 ± 0.11, 7.01 ± 0.15, and 8.56 ± 0.05 mm in the control, 2.5, 5, and 10 μg/mL groups, respectively (p < 0.05). Histomorphometry demonstrated corresponding changes in bone-cell dynamics. On day 30, osteocyte counts were 3.60 ± 0.66, 8.53 ± 0.69, 10.14 ± 0.66, and 12.03 ± 1.39 cells/high-power field, respectively, whereas osteoblast counts were 5.53 ± 0.69, 7.87 ± 0.58, 10.73 ± 0.80, and 10.80 ± 0.84 cells/high-power field, respectively. CAT activity increased, whereas SOD activity generally decreased with increasing AgNP concentration. Conclusion: A single local AgNP application was associated with concentration-dependent increases in radiographic callus formation and changes in histomorphometric indices of fracture repair, with the most pronounced responses generally observed at 10 μg/mL. AgNP exposure also altered antioxidant enzyme concentrations. However, these findings do not establish enhanced biomechanical strength or a specific mechanism of action. Further biomechanical, molecular, pharmacokinetic, and toxicological studies are required to establish functional efficacy and safety. Keywords: antioxidant enzymes, bone regeneration, fracture healing, histomorphometry, local administration, rat femoral osteotomy, silver nanoparticles, tissue remodeling.